Susquehanna International Group
HUMAW icon

Susquehanna International Group’s Humacyte Inc Warrant HUMAW Stock Holding History

Susquehanna International Group’s Portfolio HUMAW Stock Details HUMAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.07K Sell
44,517
-30,859
-41% -$3.53K ﹤0.01% 12993
2025
Q4 		$6.41K Buy
+75,376
New +$14.4K ﹤0.01% 12083
2025
Q3 		– Sell
-17,591
Closed -$7.04K – 13049
2025
Q2 		$7.04K Buy
17,591
+6,831
+63% +$2.96K ﹤0.01% 12428
2025
Q1 		$3.98K Buy
+10,760
New +$13.4K ﹤0.01% 12269
2023
Q1 		– Sell
-20,102
Closed -$7.89K – 12964
2022
Q4 		$7.89K Buy
+20,102
New +$17.8K ﹤0.01% 11972

Other funds holding HUMAW

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Susquehanna International Group's HUMAW Position: Q1 2026 in Review

Susquehanna International Group reduced its Humacyte Inc Warrant (HUMAW) stake by 41% in Q1 2026, selling an estimated $3.53K and leaving 44,517 shares worth $4.07K. The position accounts for ﹤0.01% of the portfolio, ranked #12993.

Susquehanna International Group first reported a position in HUMAW in Q4 2022 and has held it in 5 quarters since. The position peaked at $7.89K in Q4 2022. 7 funds tracked by Wall St. Rank hold HUMAW as of Q1 2026.

  • Susquehanna International Group held 44,517 shares of Humacyte Inc Warrant worth $4.07K as of Q1 2026.
  • Susquehanna International Group sold 30,859 Humacyte Inc Warrant shares in Q1 2026, an estimated $3.53K.
  • Humacyte Inc Warrant made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12993 holding.
  • Susquehanna International Group first reported a position in Humacyte Inc Warrant in Q4 2022 and has held it in 5 quarters since.
  • Susquehanna International Group's Humacyte Inc Warrant position peaked at $7.89K in Q4 2022.
  • 7 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.